{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:52:39Z","timestamp":1786719159422,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/1319-2442.256838","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T06:32:11Z","timestamp":1556001131000},"page":"315","source":"Crossref","is-referenced-by-count":8,"title":["Association of hepcidin and anemia in early chronic kidney disease"],"prefix":"10.4103","volume":"30","author":[{"given":"SatyendraKumar","family":"Sonkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NeerajKumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GyanendraKumar","family":"Sonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kauser","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.256838-1","first-page":"651","volume-title":"Diabetes treatment in patients with renal disease: Is the landscape clear enough?","author":"Ioannidis","year":"2014","journal-title":"World J Diabetes"},{"key":"key-10.4103\/1319-2442.256838-2","first-page":"351","volume-title":"Inflammation in chronic kidney disease: The role of cytokines","author":"Vianna","year":"2011","journal-title":"J Bras Nefrol"},{"key":"key-10.4103\/1319-2442.256838-3","first-page":"137","volume-title":"National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1319-2442.256838-4","first-page":"2713","volume-title":"Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The anemia in chronic heart failure: Outcomes and resource utilization (ANCHOR) study","author":"Go","year":"2006","journal-title":"Circulation"},{"key":"key-10.4103\/1319-2442.256838-5","first-page":"e99781","volume-title":"The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease","author":"Mercadal","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/1319-2442.256838-6","first-page":"1113","volume-title":"The adverse effect of iron repletion on the course of certain infections","author":"Murray","year":"1978","journal-title":"Br Med J"},{"key":"key-10.4103\/1319-2442.256838-7","first-page":"2537","volume-title":"Iron metabolism, malaria, and other infections: What is all the fuss about?","author":"Prentice","year":"2008","journal-title":"J Nutr"},{"key":"key-10.4103\/1319-2442.256838-8","first-page":"1384","volume-title":"Hepcidin for clinicians","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.256838-9","first-page":"1899","volume-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.256838-10","unstructured":"Fransen J, Welsing PM, de Keijzer RM, Van Riel PL. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 2004;62 Suppl 1:151."},{"key":"key-10.4103\/1319-2442.256838-11","doi-asserted-by":"crossref","unstructured":"Don BR, Kaysen G. Serum albumin: Relationship to inflammation and nutrition. Semin Dial 2004;17:432-7.","DOI":"10.1111\/j.0894-0959.2004.17603.x"},{"key":"key-10.4103\/1319-2442.256838-12","first-page":"4292","volume-title":"Immunoassay for human serum hepcidin","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/1319-2442.256838-13","first-page":"e0123072","volume-title":"Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease","author":"Wagner","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/1319-2442.256838-14","first-page":"848","volume-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","author":"Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-15","first-page":"1076","volume-title":"Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study","author":"Uehata","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-16","first-page":"811","volume-title":"C-reactive protein, a valuable predictive marker in chronic kidney disease","author":"Abraham","year":"2009","journal-title":"Saudi J Kidney Dis Transpl","ISSN":"https:\/\/id.crossref.org\/issn\/1319-2442","issn-type":"print"},{"key":"key-10.4103\/1319-2442.256838-17","first-page":"44","volume-title":"Relation ship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease","author":"Menon","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.256838-18","first-page":"170","volume-title":"Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin","author":"Aggarwal","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/1319-2442.256838-19","first-page":"563","volume-title":"Contribution of iron deficiency to anemia in chronic renal failure","author":"Gupta","year":"2003","journal-title":"Indian J Pathol Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0377-4929","issn-type":"print"},{"key":"key-10.4103\/1319-2442.256838-20","unstructured":"(NFHS-II) NFHS-I: Anemia among Women and Children. Mumbai: International Institute for Population Sciences; 2002. p. 141-57."},{"key":"key-10.4103\/1319-2442.256838-21","unstructured":"Sheshadri S, editor. Nutritional Anemia in South Asia. Kathmandu: UNICEF Regional office for South Asia; 1997."},{"key":"key-10.4103\/1319-2442.256838-22","first-page":"23:1631","volume-title":"Mechanisms of anemia in CKD","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.256838-23","first-page":"129","volume-title":"Iron indices in patients with functional anemia in chronic kidney disease","author":"Reddy","year":"2013","journal-title":"EJIFCC"},{"key":"key-10.4103\/1319-2442.256838-24","first-page":"2879","volume-title":"Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis","author":"Chonchol","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-25","first-page":"42:1183","volume-title":"Serum hepcidin and iron indices affect anemia status differently according to the kidney function of non-dialysis chronic kidney disease patients: Korean cohort study for outcome in patients with chronic kidney disease (KNOW-CKD)","author":"Lee","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"key-10.4103\/1319-2442.256838-26","first-page":"117:4425","volume-title":"Hepcidin and iron regulation, 10 years later","author":"Ganz","year":"2011","journal-title":"Blood"},{"key":"key-10.4103\/1319-2442.256838-27","first-page":"1:652","volume-title":"Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy","author":"Ali","year":"1982","journal-title":"Lancet"},{"key":"key-10.4103\/1319-2442.256838-28","first-page":"17:1","volume-title":"Hepcidin is a potential regulator of iron status in chronic kidney disease","author":"Tsuchiya","year":"2013","journal-title":"Ther Apher Dial"},{"key":"key-10.4103\/1319-2442.256838-29","first-page":"75:976","volume-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.256838-30","first-page":"39:883","volume-title":"Serum hepcidin concentration in chronic haemodialysis patients: Associations and effects of dialysis, iron and erythropoietin therapy","author":"Weiss","year":"2009","journal-title":"Eur J Clin Inves"},{"key":"key-10.4103\/1319-2442.256838-31","first-page":"1:191200","volume-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","author":"Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"key-10.4103\/1319-2442.256838-32","first-page":"78: 769","volume-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","author":"Ford","year":"2010","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.256838-33","first-page":"46:161","volume-title":"Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin","author":"Eleftheriadis","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/1319-2442.256838-34","first-page":"25:3996","volume-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents","author":"Tessitore","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-35","first-page":"7:e39783","volume-title":"Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents","author":"van","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1319-2442.256838-36","first-page":"31:534","volume-title":"Determinants of hepcidin in patients on maintenance hemodialysis: Role of inflammation","author":"Kuragano","year":"2010","journal-title":"Am J Nephrol"},{"key":"key-10.4103\/1319-2442.256838-37","first-page":"4:1051","volume-title":"Hepcidin \u2013 A potential novel biomarker for iron status in chronic kidney disease","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.256838-38","first-page":"4:1331","volume-title":"HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients","author":"Valenti","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.256838-39","first-page":"110:e572","volume-title":"CDC\/AHA workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: Laboratory tests available to assess inflammation - Performance and standardization: A background paper","author":"Roberts","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/1319-2442.256838-40","first-page":"107:363","volume-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"key-10.4103\/1319-2442.256838-41","first-page":"297:611","volume-title":"Development and validation of improved algorithms for the assessment of global cardio vascular risk in women: The Reynolds risk score","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"key-10.4103\/1319-2442.256838-42","first-page":"1770","volume-title":"Serum albumin concentration and risk of endstage renal disease: The REGARDS study","author":"Walther","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-43","first-page":"366","volume-title":"Iron status and inflammation in early stages of chronic kidney disease","author":"\u0141ukaszyk","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"key-10.4103\/1319-2442.256838-44","first-page":"1665","volume-title":"Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients","author":"Besarab","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.256838-45","first-page":"60","volume-title":"Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation","author":"Eleftheriadis","year":"2016","journal-title":"Exp Hematol"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:44:41Z","timestamp":1786715081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.256838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["256838"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.256838","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}